 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| PZOO Sub Announces Revenues Earlier this Week and Now Expands Markets into Recreational MJ Testing |
|
 Hot Stock to Watch |
Company: Pazoo, Inc. (Pink Sheets: PZOOD)
|
Last:
Price: 0.0082
Change (%): + 0.0002 (2.50)
Volume: 106,764 |
 |
Pazoo, Inc. Subsidiary MA & Associates, LLC Applies for Recreational Testing License to Expand Client Base
FLORHAM PARK, N.J., May 19, 2017 /PRNewswire/ - Pazoo, Inc. (OTC Pinks: PZOOD) is pleased to announce that its wholly owned subsidiary, MA & Associates, LLC, a marijuana testing laboratory in Las Vegas, Nevada, has submitted the necessary documentation requested by the City of Las Vegas in order to obtain its recreational testing license. Currently, the laboratory has obtained the City of Las Vegas business license to operate as a medical marijuana independent testing facility which may operate under its provisional license.
Furthermore, laboratory work has begun in the genetics arena first with the development of molecular markers to sex plants. Validation should be completed prior to receipt of our recreational license, so we can provide testing to all growers and clients moving forward.
Since our previous press release, announcing MA & Associates, LLC taking in its first revenue, we have acquired additional growers and continue to increase our client base.
CEO of Pazoo, Inc., David Cunic said, “We couldn’t be more thrilled with the direction the Las Vegas laboratory has taken. Our goal is simple. We want to provide testing options for both recreational and medicinal marijuana. By taking all the correct steps and being proactive, the team is moving forward, accordingly.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
